{"disease":{"id":"late-infantile-metachromatic-leukodystrophy","name":"late infantile metachromatic leukodystrophy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00633139","title":"Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT00681811","title":"Open-Label Extension Study of Recombinant Human Arylsulfatase A (HGT-1111) in Late Infantile MLD","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Shire","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}